OUR TEAM

Jay B Lichter

Jay B. Lichter, PH.D.

Managing Partner

Jay B. Lichter, Ph.D. is an experienced biotechnology and pharmaceutical business executive and investor with 25 years of experience in management, scientific research, and business development. Throughout his career, Dr. Lichter has applied his exceptional combination of business acumen and deep technical knowledge to creating commercially successful biotech companies and…

Tighe M Reardon

Tighe M. Reardon, CPA

Chief Financial Officer & Managing Partner

Lorem ipsum dolor sit amet, consect etuer adipiscing elit, sed diam.

Sanford J Madigan

Lorem ipsum dolor sit amet, consect etuer adipiscing elit, sed diam.

Sergio G Duron

Sergio G. Duron, PH.D.

Managing Partner

Lorem ipsum dolor sit amet, consect etuer adipiscing elit, sed diam.

Kevin J Kinsella

Kevin J. Kinsella

Founding Partner - Emeritus

Lorem ipsum dolor sit amet, consect etuer adipiscing elit, sed diam.

David Campbell

David founded Janux in 2017 to develop tumor specific cancer therapeutics in order to improve patient safety for this important class of drugs. David brings more than 25 years of seasoned executive management, company creation and successful partnering coupled with broad disease and drug development expertise to his role as…

Neil Gibson

Neil Gibson, PH.D.

Senior Advisor

Dr. Gibson, currently serves as the CEO of Adanate and was the CEO of PDI Therapeutics (recently transacted with Cullinan). Dr. Gibson has held various senior positions within the biotechnology and pharmaceutical industry including Senior Vice President of BioAtla; Chief Scientific Officer of Regulus Therapeutics; Chief Scientific Officer and Oncology…

Thomas Diraimondo

Tommy DiRaimondo, Ph.D. joined the Accelerator in 2013 and currently serves as the Director of Research at Janux Therapeutics, an Avalon portfolio company. Previously, Tommy was the co-founder of Sitari Pharma that spawned from his predoctoral work at Stanford University. Tommy was a key leader in the Sitari Pharma drug…

Jason Roland

Jason Roland, Ph.D. joined the Accelerator in 2015 and brings over 10 years of experience leading medicinal chemistry and drug discovery programs. While at the Accelerator, Dr. Roland was involved with the creation of Nerio Therapeutics and Anexigen, where he currently serves as the Director of Chemistry and Drug Discovery.…

Jennifer Arthur

Jennifer Arthur

VP, Finance

Jennifer Arthur joined the Accelerator at its inception in 2013. Ms. Arthur has over 20 years of experience in accounting and finance, including more than 15 years in leadership roles in the life science industry ranging from private start-ups to public commercial organizations. Prior to joining the Accelerator, Ms. Arthur…

Avalon Bioventures